610 Views | 86 Downloads
Corresponding author: Gretchen N Neigh, Department of Psychiatry and Behavioral Sciences, Emory University, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA. Email: gretchen.neigh@emory.edu.
Gretchen N Neigh, PhD, receives research funding from NARSAD, AHA, NIH, and GlaxoSmithKline.
Michael J Owens, PhD, receives research funding from NIH, Eli Lilly, Lundbeck, Cyberonics, Ortho-McNeil Janssen, AstraZeneca, and Dainippon Sumitomo. Dr Owens consults for H Lundbeck A/S.
Charles B Nemeroff, MD, PhD, has research funding from NIH, is on the Scientific Advisory Board for AFSP, AstraZeneca, Forest Laboratories, NARSAD, Quintiles, Janssen/Ortho-McNeil, PharmaNeuroboost, and Mt Cook Pharma; is a stockholder in Corcept, Revaax, NovaDel Pharma, CeNeRx, and PharmaNeuroboost; and is on the Board of directors for American Foundation for Suicide Prevention (AFSP), George West Mental Health Foundation, NovaDel Pharma, and Mt Cook Pharma.
Dr Nemeroff and Dr Owens have a patent entitled ‘A method to estimate transporter occupancy.'
Dr Nemeroff has a patent on the method and devices for transdermal delivery of lithium (US 6,375,990 B1).
© 2010 Nature Publishing Group